Clinical Trial

Treatment of Retinal Detachment in People Who Have Not Had Cataract Surgery With Vitrectomy vs Vitrectomy and Cataract Removal

Study acronym: COMBAT
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Background and study aims The retina is the layer at the back of the eye that allows us to see. Sometimes, it can detach from the wall of the eye, causing a condition called rhegmatogenous retinal detachment (RRD), which leads to vision loss and requires surgery. The most common surgery for RRD is vitrectomy, but this can lead to complications like cataracts, which worsen over time and need to be removed with another surgery. Cataract surgery involves replacing the cloudy lens with a clear artificial one. Currently, it's unclear whether it's better to perform both surgeries at the same time or separately. The COMBAT study aims to find out which approach is best by comparing the outcomes of patients who have vitrectomy alone versus those who have both surgeries (vitrectomy and cataract surgery by phacoemulsification and intraocular lens \[IOL\] implantation) together. Who can participate? Adults aged 50 and older who have RRD but are not highly myopic (less than -6 diopters or an axial length of 26.5 mm or less) and have not had previous vitreoretinal surgery. Participants must be scheduled for a pars plana vitrectomy to repair their RRD. What does the study involve? Participants will be randomly assigned to one of two groups: one group will have vitrectomy first and, if needed, cataract surgery later; the other group will have both surgeries at the same time. The study will compare their vision, the number of successful retina reattachments, health related and visual related quality of life, patient satisfaction, complications, additional surgeries and procedures, and costs.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-27.
Trial Details
NCT Number NCT06997874
Lead Sponsor Queen's University, Belfast
Collaborators: Northern Ireland Clinical Trials Unit
Conditions Rhegmatogenous Retinal Detachment
Enrollment 276 participants
Start Date 2025-05-16
Primary Completion 2028-05-08 (estimated)
Study Completion 2028-05-08 (estimated)
Updated on ClinicalTrials.gov 2026-06-10